16.37USD+0.68%Mkt Cap: 994.39M USDP/E: —Last update: 2026-06-01
Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. It engages in the development of CLN-978, a CD19xCD3 bispecific T cell …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap994.39M USD
Enterprise Value660.87M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-219.88M USD
Revenue/Share—
Last Price16.37 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees109
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.46
PEG—
EV/EBITDA-2.75
EV/Revenue—
P/S—
P/B2.76
EPS (TTM)-3.37
EPS (Forward)-2.54
52W Range
5.68097% of range16.74
52W High16.74 USD
52W Low5.680 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-53.80%
ROA-49.04%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-175.75M USD
CapEx (TTM)49.00K USD
FCF Margin—
FCF Yield-10.34%
Net Debt-349.50M USD
Net Debt/EBITDA1.46
Balance Sheet
Debt/Equity0.01
Current Ratio10.28
Quick Ratio10.09
Book Value/Sh5.959 USD
Cash/Share5.726 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)31.45 USD
Target Range23.00 USD – 38.00 USD
# Analysts11
Ownership
Shares Out.61.46M
Float44.27M
Insiders0.45%
Institutions107.77%
Short Interest
Short Ratio10.4d
Short % Float20.04%
Short % Out.14.12%
Shares Short8.68M
Short (prev mo.)8.11M
Technical
SMA 5014.30 (+14.5%)
SMA 20010.93 (+49.8%)
Beta-0.09
S&P 52W Chg27.94%
Avg Vol (30d)870.41K
Avg Vol (10d)992.44K
Technical Indicators
RSI (14)61.0
MACD0.3280
MACD Signal0.2407
MACD Hist.+0.0872
BB Upper16.78 USD
BB Middle15.06 USD
BB Lower13.34 USD
BB Width22.80%
ATR (14)1.048 USD
Vol Ratio (20d)1.22x